BACKGROUND: Secondary analyses of data from a large randomized clinical trial have suggested that intake of the trace element selenium reduces risk of colorectal neoplasia, but epidemiologic studies have not shown a consistent protective association. METHODS: We conducted a combined analysis of data from three randomized trials--the Wheat Bran Fiber Trial, the Polyp Prevention Trial, and the Polyp Prevention Study--which tested the effects of various nutritional interventions for colorectal adenoma prevention among participants who recently had an adenoma removed during colonoscopy. Selenium concentrations were measured from blood specimens from a total of 1763 trial participants, and quartiles of baseline selenium were established from the pooled data. To estimate the association between baseline selenium and colorectal adenoma risk, odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression modeling. All statistical tests were two-sided. RESULTS: Individual study results among participants whose blood selenium concentrations were in the highest versus the lowest quartile varied in magnitude (Polyp Prevention Trial: OR = 0.67, 95% CI = 0.43 to 1.05; P(trend) = .21; Wheat Bran Fiber Trial: OR = 0.66, 95% CI = 0.40 to 1.10; P(trend) = .13, and Polyp Prevention Study: OR = 0.57, 95% CI = 0.34 to 0.95, P(trend) = .04). Analyses of the pooled data showed that individuals whose blood selenium values were in the highest quartile (median = 150 ng/mL) had statistically significantly lower odds of developing a new adenoma compared with those in the lowest quartile (OR = 0.66, 95% CI = 0.50 to 0.87; P(trend) = .006). CONCLUSIONS: The inverse association between higher blood selenium concentration and adenoma risk supports previous findings indicating that higher selenium status may be related to decreased risk of colorectal cancer.
RCT Entities:
BACKGROUND: Secondary analyses of data from a large randomized clinical trial have suggested that intake of the trace element selenium reduces risk of colorectal neoplasia, but epidemiologic studies have not shown a consistent protective association. METHODS: We conducted a combined analysis of data from three randomized trials--the Wheat Bran Fiber Trial, the Polyp Prevention Trial, and the Polyp Prevention Study--which tested the effects of various nutritional interventions for colorectal adenoma prevention among participants who recently had an adenoma removed during colonoscopy. Selenium concentrations were measured from blood specimens from a total of 1763 trial participants, and quartiles of baseline selenium were established from the pooled data. To estimate the association between baseline selenium and colorectal adenoma risk, odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression modeling. All statistical tests were two-sided. RESULTS: Individual study results among participants whose blood selenium concentrations were in the highest versus the lowest quartile varied in magnitude (Polyp Prevention Trial: OR = 0.67, 95% CI = 0.43 to 1.05; P(trend) = .21; Wheat Bran Fiber Trial: OR = 0.66, 95% CI = 0.40 to 1.10; P(trend) = .13, and Polyp Prevention Study: OR = 0.57, 95% CI = 0.34 to 0.95, P(trend) = .04). Analyses of the pooled data showed that individuals whose blood selenium values were in the highest quartile (median = 150 ng/mL) had statistically significantly lower odds of developing a new adenoma compared with those in the lowest quartile (OR = 0.66, 95% CI = 0.50 to 0.87; P(trend) = .006). CONCLUSIONS: The inverse association between higher blood selenium concentration and adenoma risk supports previous findings indicating that higher selenium status may be related to decreased risk of colorectal cancer.
Authors: Stephen J Glatt; Ian P Everall; William S Kremen; Jacques Corbeil; Roman Sásik; Negar Khanlou; Mark Han; Choong-Chin Liew; Ming T Tsuang Journal: Proc Natl Acad Sci U S A Date: 2005-10-13 Impact factor: 11.205
Authors: Andrew G Renwick; Lars O Dragsted; Reg J Fletcher; Albert Flynn; John M Scott; Sandra Tuijtelaars; T Wildemann Journal: Eur J Nutr Date: 2008-01-14 Impact factor: 5.614
Authors: Christina Dawn Williams; Jessie A Satia; Linda S Adair; June Stevens; Joseph Galanko; Temitope O Keku; Robert S Sandler Journal: Cancer Causes Control Date: 2010-03-30 Impact factor: 2.506
Authors: G Bermano; V Pagmantidis; N Holloway; S Kadri; N A G Mowat; R S Shiel; J R Arthur; J C Mathers; A K Daly; J Broom; J E Hesketh Journal: Genes Nutr Date: 2007-10-13 Impact factor: 5.523
Authors: Patricia Thompson; Denise J Roe; Liane Fales; Julie Buckmeier; Fang Wang; Stanley R Hamilton; Achyut Bhattacharyya; Sylvan Green; Chiu-Hsieh Hsu; H-H Sherry Chow; Dennis J Ahnen; C Richard Boland; Russell I Heigh; David E Fay; Maria Elena Martinez; Elizabeth Jacobs; Erin L Ashbeck; David S Alberts; Peter Lance Journal: Cancer Prev Res (Phila) Date: 2012-10-11
Authors: Luigina Bonelli; Matteo Puntoni; Beatrice Gatteschi; Paolo Massa; Guido Missale; Francesco Munizzi; Laura Turbino; Vincenzo Villanacci; Andrea De Censi; Paolo Bruzzi Journal: J Gastroenterol Date: 2012-10-13 Impact factor: 7.527